What medications should be included in a palliative care P (Preferred) drug list?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Essential Medications for Palliative Care P-Drug List

A comprehensive palliative care P-drug list should include morphine, midazolam, haloperidol, and an antimuscarinic agent as the core essential medications, with additional medications for specific symptom management based on patient needs. 1

Core Essential Medications

Pain Management

  • Morphine - First-line opioid for moderate to severe pain
    • Starting dose: 5 mg PO every 4 hours for opioid-naive patients; 10 mg PO every 4 hours for patients previously on weak opioids 2
    • For acute progressive dyspnea: 2.5-10 mg PO every 2 hours PRN or 1-3 mg IV every 2 hours PRN 3
    • Patients on chronic opioids may need dose increases of approximately 25% 3
    • Available in multiple formulations: oral solution, tablets, injectable forms 4

Anxiety, Agitation, and Sedation

  • Midazolam - First-line benzodiazepine for anxiety, agitation, and palliative sedation
    • Starting dose: 0.5-1 mg/hour continuous infusion or 1-5 mg PRN 3
    • Usual effective dose: 1-20 mg/hour 3
    • Advantages: Rapid onset, can be administered IV or SC, can be co-administered with morphine or haloperidol 3
    • For refractory symptoms requiring sedation: Can be titrated to achieve desired level of sedation 5

Delirium and Nausea

  • Haloperidol - First-line antipsychotic for delirium and nausea
    • Effective for managing signs and symptoms of delirium 1
    • Can help with nausea and vomiting 1
    • Alternative neuroleptics include:
      • Levomepromazine: Starting dose 12.5-25 mg, with usual effective dose of 12.5-25 mg every 8 hours 3
      • Chlorpromazine: Starting dose 12.5 mg IV/IM every 4-12 hours or 25-100 mg rectally 3

Respiratory Secretions

  • Antimuscarinic agent - For managing respiratory tract secretions
    • Options include:
      • Scopolamine: 0.4 mg subcut every 4 hours PRN or 1.5 mg patches (1-3 patches every 3 days) 3
      • Atropine: 1% ophthalmic solution 1-2 drops SL every 4 hours PRN 3
      • Glycopyrrolate: 0.2-0.4 mg IV or subcut every 4 hours PRN 3

Additional Essential Medications by Symptom

Dyspnea Management

  • Oxygen therapy - For symptomatic hypoxia 3
  • Benzodiazepines - For dyspnea associated with anxiety
    • Lorazepam: 0.5-1 mg PO every 4 hours PRN 3

Gastrointestinal Symptoms

  • Laxatives for constipation prevention and management

    • Senna with docusate: 2-3 tablets BID-TID 3
    • Bisacodyl: 10-15 mg daily-TID 3
    • Methylnaltrexone: 0.15 mg/kg SC every other day for opioid-induced constipation 3
  • Anti-diarrheals

    • Loperamide: 4 mg PO initially, then 2 mg after each loose stool (max 16 mg/day) 3
    • Diphenoxylate/atropine: 1-2 tablets PO every 6 hours PRN (max 8 tablets/day) 3
  • Antiemetics

    • Metoclopramide: 10-20 mg PO QID for nausea and as prokinetic agent 3, 6
    • Ondansetron: For chemotherapy-induced nausea

Sleep Disturbances

  • Trazodone: 25-100 mg PO at bedtime 3
  • Mirtazapine: 7.5-30 mg PO at bedtime 3
  • Zolpidem: 5 mg PO at bedtime 3

For Refractory Symptoms Requiring Deep Sedation

  • Phenobarbital

    • Starting dose: 1-3 mg/kg SC or IV bolus, followed by infusion of 0.5 mg/kg/hour 3
    • Usual maintenance dose: 50-100 mg/hour 3
    • Advantages: Rapid onset, anticonvulsant properties 3
  • Propofol

    • For cases where benzodiazepines and barbiturates are ineffective
    • Loading dose of 20 mg, followed by infusion of 50-70 mg/hour 3
    • Requires specialized monitoring and administration 3

Practical Considerations

  • Medications for symptom palliation should be continued unless ineffective or causing distressing side effects 3
  • Medications inconsistent with comfort goals can be discontinued 3
  • Route of administration should be adjusted based on patient's condition (oral, IV, SC, rectal) 3
  • Provision for breakthrough symptom management should always be included 3
  • Pharmacokinetics may be altered in terminally ill patients due to physiological changes at end of life 7
  • Consider dose adjustments for patients with renal or hepatic impairment 6

Common Pitfalls to Avoid

  • Failing to distinguish between anxiety and delirium (benzodiazepines can worsen delirium) 3
  • Using opioids alone for dyspnea when anxiety is a significant component 3
  • Inadequate breakthrough dosing for pain and other symptoms 3
  • Abrupt discontinuation of medications, especially opioids and benzodiazepines 3
  • Prescribing liquid opioids in milliliters instead of milligrams when multiple concentrations are available 8
  • Not making clear the indication and intended duration for steroids 8
  • Using oxygen for symptomatic relief of breathlessness in the absence of hypoxia 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.